Quinton Cardiology Sets Aside IPO Funds To Solidify International Presence
This article was originally published in The Gray Sheet
Executive Summary
Diagnostic cardiology firm Quinton Cardiology Systems expects to use a portion of its initial public offering proceeds to fund international expansion, R&D and potential acquisitions